318 related articles for article (PubMed ID: 15781120)
1. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD; Wang D; Sadee W
Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
Hiratsuka M; Mizugaki M
Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
[No Abstract] [Full Text] [Related]
4. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
Ozawa S
Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
[TBL] [Abstract][Full Text] [Related]
6. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial pharmacogenetics.
Wilke RA; Reif DM; Moore JH
Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in breast cancer therapy.
Tan SH; Lee SC; Goh BC; Wong J
Clin Cancer Res; 2008 Dec; 14(24):8027-41. PubMed ID: 19088019
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
12. Comparative and veterinary pharmacogenomics.
Mosher CM; Court MH
Handb Exp Pharmacol; 2010; (199):49-77. PubMed ID: 20204583
[TBL] [Abstract][Full Text] [Related]
13. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
15. Genetic strategies for the personalization of antipsychotic treatment.
Kerwin RW; Mancama DT; Arranz MJ
Expert Rev Mol Diagn; 2001 Sep; 1(3):275-80. PubMed ID: 11901832
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance.
Puga A; Nebert DW; McKinnon RA; Menon AG
Crit Rev Toxicol; 1997 Mar; 27(2):199-222. PubMed ID: 9099519
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Wang L; Weinshilboum R
Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
[TBL] [Abstract][Full Text] [Related]
18. [Tailor-made drug therapy].
Ozawa S; Sawada J
Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
[TBL] [Abstract][Full Text] [Related]
19. [Customized drug therapy--how near is the goal?].
Spigset O
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2390-6. PubMed ID: 16998553
[TBL] [Abstract][Full Text] [Related]
20. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
